BE20260040 - Procurement of Antivirals - Bictegravir + Emtricitabine + Tenofovir Alafenamide - 1st Semester

This tender, identified by reference BE20260040, is for the procurement of antiviral medication. Specifically, the required drug is a combination of Bictegravir, Emtricitabine, and Tenofovir Alafenamide. The procurement covers the first semester of the year. The objective is to secure a supply of this critical antiviral treatment for patients. Bidders are expected to provide high-quality pharmaceutical products that meet all regulatory and therapeutic standards. The tender process will outline the specific quantities, delivery schedules, and quality assurance requirements. This acquisition is vital for public health initiatives aimed at managing viral infections. Interested pharmaceutical companies and distributors are invited to review the tender documents and submit their competitive bids. The selection process will focus on ensuring the reliability of supply, product quality, and adherence to all contractual obligations.

This is a supplies contract in the health and medical services and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 471,182.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.